BHC - Bausch Health Companies Inc.
This page shows which of the focused investors we track hold BHC and how their positions changed, so you can see how much conviction the group has in the stock.
In Q1 2022 it was held by 7 managers with an aggregate reported value of $1.29B, which is 0.11% of the combined portfolio.
As of Q1 2022, 7 tracked institutional managers held BHC (Bausch Health Companies Inc.) with an aggregate reported value of $1.29B — 0.11% of the combined AlphaBaseline portfolio.
Get email alerts when a tracked manager trades BHC — sign in or create a free account.
- Source
- Curated SEC 13F filings
- Period
- Q1 2022
- Ticker
- BHC
13F data is delayed and excludes shorts/non-13F assets.
Holders
| 1 | Carl Icahn - Icahn Capital Management | 3.63% | - | 34,721,118 | $793.38M |
| 2 | ValueAct Capital - ValueAct Capital | 4.54% | Reduce -7.6% | 14,430,901 | $329.75M |
| 3 | Bill Miller - Miller Value Partners | 2.25% | Reduce -0.3% | 3,055,227 | $69.81M |
| 4 | Leon Cooperman - Leon Cooperman | 3.01% | - | 2,500,000 | $57.13M |
| 5 | Francis Chou - Chou Associates | 9.30% | - | 765,000 | $17.48M |
| 6 | Francis Chou - Chou Associates | 7.29% | - | 600,000 | $13.71M |
| 7 | Samantha McLemore - Patient Capital Management | 2.10% | Reduce -6.5% | 271,300 | $6.2M |
Loading holder history for BHC…